FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 360:e14 March 5, 2009 Number 10 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Editorial by Hlatky, M. A. Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Ridker, P. M

In November 2008, we published the results of the Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER; ClinicalTrials.gov number, NCT00239681 [ClinicalTrials.gov] ),¹ along with a new online Clinical Directions interactive feature that allowed readers to vote and comment on two questions related to this major trial. We asked whether the results of JUPITER should change the approach to laboratory screening of apparently healthy adults or the therapeutic use of statins in apparently healthy adults.

Over 18 days, 2553 people voted, and the votes were split almost evenly between the two choices. In all, 49% . . . [Full Text of this Article]

This article has been cited by other articles:

• Haffey, T. A. (2009). How to avoid a heart attack: putting it all together.. JAOA: Journal of the American Osteopathic Association 109: S14-S20 [Abstract] [Full Text]